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Microglia-derived TNFa induces apoptosis in neural
precursor cells via transcriptional activation of the
Bcl-2 family member Puma
J Guadagno1,2, X Xu1, M Karajgikar1, A Brown1 and SP Cregan*,1,2

Neuroinflammation is a common feature of acute neurological conditions such as stroke and spinal cord injury, as well as
neurodegenerative conditions such as Parkinson’s disease, Alzheimer’s disease, and amyotrophic lateral sclerosis. Previous
studies have demonstrated that acute neuroinflammation can adversely affect the survival of neural precursor cells (NPCs) and
thereby limit the capacity for regeneration and repair. However, the mechanisms by which neuroinflammatory processes induce
NPC death remain unclear. Microglia are key mediators of neuroinflammation and when activated to induce a pro-inflammatory
state produce a number of factors that could affect NPC survival. Importantly, in the present study we demonstrate that tumor
necrosis factor a (TNFa) produced by lipopolysaccharide-activated microglia is necessary and sufficient to trigger apoptosis in
mouse NPCs in vitro. Furthermore, we demonstrate that microglia-derived TNFa induces NPC apoptosis via a mitochondrial
pathway regulated by the Bcl-2 family protein Bax. BH3-only proteins are known to play a key role in regulating Bax activation
and we demonstrate that microglia-derived TNFa induces the expression of the BH3-only family member Puma in NPCs via an
NF-jB-dependent mechanism. Specifically, we show that NF-jB is activated in NPCs treated with conditioned media from
activated microglia and that Puma induction and NPC apoptosis is blocked by the NF-jB inhibitor BAY-117082. Importantly, we
have determined that NPC apoptosis induced by activated microglia-derived TNFa is attenuated in Puma-deficient NPCs,
indicating that Puma induction is required for NPC death. Consistent with this, we demonstrate that Puma-deficient NPCs exhibit
an B13-fold increase in survival as compared with wild-type NPCs following transplantation into the inflammatory environment
of the injured spinal cord in vivo. In summary, we have identified a key signaling pathway that regulates neuroinflammation
induced apoptosis in NPCs in vitro and in vivo that could be targeted to promote regeneration and repair in diverse neurological
conditions.
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The persistence of neural precursor cells (NPCs) in distinct
niches of the adult brain and spinal cord suggests the potential
for regeneration in the affected nervous system.1 Indeed,
numerous studies have reported evidence of increased
neurogenesis in animal models of cerebral ischemia,
epilepsy, and spinal cord injury (SCI), as well as in models
of neurodegenerative disease including Alzheimer’s, Parkinson’s, and Huntington’s disease.2 However, the hostile
environment of the injured or degenerating nervous system
is known to be detrimental to the survival of NPCs and
newborn neurons thereby limiting the capacity for regeneration and repair.3,4
Neuroinflammation is a common feature of many acute
and chronic neurological conditions.5 Neuroinflammatory
1

processes can have both beneficial and detrimental effects
on neurogenesis in the affected nervous system depending on
the nature and duration of the inflammatory response.2,6
Microglia cells are the innate immune cells of the central
nervous system and are primary regulators of neuroinflammatory responses.7 During brain injury, microglia cells
become activated and produce a number of anti- and
pro-inflammatory factors that can modulate neurogenesis.2
On the one hand, it has been reported that microglia can
produce growth factors and chemokines that can promote the
proliferation and recruitment of NPCs to sites of injury.8,9
On the other hand, microglia can also produce pro-inflammatory cytokines such as tumor necrosis factor a (TNFa),
interleukin (IL)-1b, and IL-6 as well as reactive oxygen
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species that can inhibit neurogenesis and induce NPC
apoptosis.10–13 TNFa can signal through its cognate receptors
TNFR1 and TNFR2 to promote cell survival or cell death.14,15
Moreover, depending on the cellular context, TNFa can
induce cell death via caspase-8-mediated apoptosis or
RIPK1-mediated necroptosis.16,17 However, the mechanism
by which TNFa signaling affects NPC survival has not been
defined.
The Bcl-2 gene family consists of pro-apoptotic and prosurvival members that interact physically and functionally to
regulate apoptosis.18 In response to apoptotic stimuli, the
Bcl-2 family members Bax and/or Bak oligomerize in the
mitochondria and induce membrane permeabilization, leading
to the release of factors such as cytochrome-c and Smac/
Diablo that promote caspase activation and apoptotic cell
death.19,20 Bax/Bak activation requires the actions of a third
group of Bcl-2 family proteins known as the BH3-domain-only
subfamily that promote apoptosis by binding to and neutralizing pro-survival Bcl-2 proteins such as Bcl-2, Bcl-XL, and
Mcl-1.21 Several BH3-domain only proteins have been
identified and specific members can be activated through
transcriptional mechanisms and/or post-translational
mechanisms.22 For example, the BH3-only family member
Puma is known to be regulated through p53-mediated
transcriptional activation whereas the BH3-only protein
Bid is regulated primarily through proteolytic cleavage.23–25
The existence of multiple BH3-domain only proteins and
activation pathways is thought to underlie the cell type and
stimulus-specific nature of apoptosis regulation. Importantly,
the Bcl-2 family proteins involved in the regulation of NPC
apoptosis induced by neuroinflammatory conditions has not
been investigated and is the focus of this study.
The nuclear factor kB (NF-kB) family of transcription factors
are ubiquitously expressed and can be activated by a diverse
array of stimuli.26 NF-kB complexes can regulate the
expression of genes that either promote survival or cell death
depending on the cellular milieu.27,28 In the present study, we
demonstrate that TNFa produced by lipopolyssacharideactivated microglia induces NPC apoptosis via a mechanism
involving the NF-kB-dependent transcriptional induction of the
BH3-only family member Puma. Furthermore, we demonstrate that Puma plays a critical role in regulating NPC
apoptosis induced by activated microglia in vitro and in the
neuroinflammatory environment of the injured spinal cord
in vivo.
Results
Soluble factors released by activated microglia induce
NPC apoptosis. To investigate the mechanism by which
microglia cells trigger NPC apoptosis, we utilized the EOC-20
mouse microglia cell line as a homogeneous and renewable
source of microglia cells.29 We first examined whether EOC-20
microglia cells when activated by the bacterial endotoxin
lipopolysaccharide (LPS) to induce a pro-inflammatory
phenotype secrete factors that promote NPC apoptosis.
To examine the effects of microglia-derived factors on
NPC survival, culture media was removed from adherent
NPCs and replaced with unconditioned stem cell media or
conditioned stem cell media from either unactivated microglia
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or LPS-activated microglia and apoptosis was assessed by
Hoechst 33342 staining. As shown in Figures 1a and b, the
fraction of apoptotic cells was increased in NPCs cultured in
LPS-activated microglia conditioned stem cell media (MCM)
in a concentration-dependent manner (Figures 1a and b).
In contrast, NPC apoptosis was not increased by conditioned
media (CM) from unactivated microglia or unconditioned
media directly supplemented with LPS (Figures 1a and b).
Consistent with this, NPCs treated with CM from activated
microglia but not unactivated microglia exhibited a significant
increase in caspase-3-like activity (Figure 1c). Furthermore,
cell death induced by activated microglia conditioned media
(MCM) as assessed by Live/Dead assay was markedly
reduced in the presence of the pan-caspase inhibitor z-VADFMK consistent with a predominate role of apoptotic cell
death in these conditions (Figure 1d). Taken together, these
findings indicate that soluble factors released from activated
microglia can trigger apoptosis in NPCs.
TNFa released from activated microglia induces NPC
apoptosis. Activated microglia release a variety of soluble
factors including reactive oxygen/nitrogen species, chemokines, and both pro- and anti-inflammatory cytokines.7 ELISA
analysis of CM from LPS-stimulated microglia revealed a
significant increase in TNFa levels as well as several other
pro-inflammatory factors in CM from LPS-stimulated microglia as compared with unactivated microglia (Figure 2a, data
not shown). TNFa is a potent pro-inflammatory cytokine that
has been reported to affect neurogenesis13,30–33 and exerts
its effects on cells by activating two receptor subtypes
on target cell membranes: TNF receptor-1 (TNFR1), and
TNF receptor-2 (TNFR2).14 We examined the expression of
TNFR1 and TNFR2 in NPCs treated with MCM by qRT-PCR
and western blot. NPCs exposed to MCM exhibited a marked
increase in Tnfr1 mRNA levels (Figure 2b) as well as a
corresponding increase in TNFR1 protein levels (Figure 2c).
In contrast, Tnfr2 mRNA levels were not altered by treatment
with MCM (Figure 2b) and TNFR2 protein was not detectable
in NPCs (data not shown). Given this increase in TNFR1
expression, we examined whether TNFa produced by
activated microglia contributes to NPC apoptosis. To address
this, we pre-treated MCM with a TNFa-neutralizing antibody
or IgG antibody as a control and then examined NPC
apoptosis. The efficacy of the antibody to neutralize TNFa in
MCM was verified by ELISA (Figure 2a). As shown in
Figure 2d, NPC apoptosis induced by activated MCM was
significantly reduced in the presence of the TNFa-neutralizing antibody but not IgG control antibody. Furthermore, we
found that addition of recombinant TNFa (rTNFa) was
sufficient to induce NPC apoptosis and that this could be
attenuated by the addition of the TNFa-neutralizing antibody
or the pan-caspase inhibitor zVAD-FMK (Figures 2e and f).
Taken together, these results indicate that TNFa is a key
mediator of NPC apoptosis induced by activated microglia.
Activated microglia/TNFa induces NPC apoptosis via
a Bax-mediated mitochondrial pathway. Depending on
the cell type, TNFa has been reported to trigger apoptosis through either a mitochondrial-dependent pathway
or a mitochondrial-independent pathway involving direct
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Figure 1 LPS-activated microglia release soluble factors that induce NPC apoptosis. NPCs were cultured for 2 days in stem cell media and then media was replaced with
either unconditioned stem cell media (c) or microglia conditioned stem cell media from unactivated microglia (0% MCM) or LPS-activated microglia (25–100% MCM). Activated
microglia conditioned media was left undiluted (100%) or diluted to 75%, 50%, or 25% with unactivated microglia conditioned media. NPCs maintained in unconditioned stem
cell media and directly treated with LPS (10 ng/ml) are labeled as LPS. (a) NPCs were stained at 72 h with Hoechst 33342 and the fraction of apoptotic cells was determined by
examining nuclear morphology (n ¼ 4, *Po0.05). (b) Representative images of Hoechst-stained NPCs maintained in unconditioned stem cell media (Ctrl), or treated with
conditioned media from unactivated microglia (MCM) or LPS-activated microglia (a-MCM) for 72 h. Note the marked increase in NPCs exhibiting chromatin condensation and
pyknotic/fragmented nuclei following incubation in conditioned media from LPS-activated microglia. Nestin immunostaining (green) demonstrates that the vast majority of
NPCs remain in an undifferentiated state. Scale bar, 20 mm. (c) Protein extracts were obtained from NPCs at 72 h and assayed for caspase-3-like activity. Caspase-3 activity in
NPCs treated with microglia conditioned media is reported as fold increase over that in NPCs cultured in unconditioned stem cell media (n ¼ 3, *Po0.05). (d) NPCs were
cultured in unconditioned stem cell media (c), conditioned media from unactivated microglia (MCM) or conditioned media from LPS-activated microglia (a-MCM) in the
presence of the pan-caspase inhibitor z-VAD-FMK (100 mM) or DMSO as a vehicle control. The fraction of dead (ethidium positive) NPCs was determined by Live/Dead assay
at 48 h (n ¼ 4, *Po0.05)

activation of caspase-3 by caspase-8.34 The pro-apoptotic
Bcl-2 family proteins Bax and Bak are known to be essential
regulators of mitochondrial mediated apoptotic pathways.20
Therefore, to determine whether microglia-derived TNFa
induces NPC apoptosis via a mitochondrial pathway, we
examined survival in NPCs derived from Bax-deficient mice
and wild-type littermates by Live/Dead assay. As shown in
Figure 3, NPC death induced by either LPS-activated MCM
or rTNFa was markedly reduced in Bax-deficient NPC
cultures. Furthermore, Mitotracker Red staining revealed
that both a-MCM and rTNFa treatments caused mitochondrial depolarization in a significant portion of wild-type NPCs
but not Bax-null NPCs (Figure 3b). These results suggest
that activated microglia-derived TNFa induces NPC apoptosis primarily through a mitochondrial-dependent pathway
regulated by the Bcl-2 protein family.
Activated microglia-derived TNFa induces Puma expression via an NF-jB-dependent pathway. BH3-only proteins
are known to play a key role in regulating Bax activation with
distinct family members being activated in a cell type and
stimulus-specific manner.18 The BH3-only protein Bid has
previously been implicated in death receptor mediated
apoptotic pathways.23,35 It has been proposed that when
engaged, death receptors such as Fas and TNFR recruit and

activate caspase-8, which can then cleave Bid into its active,
truncated form tBid. Therefore, we examined tBid production
in NPCs treated with LPS-activated MCM. While we could
detect tBid in NPCs treated with activated MCM, the
exposure time required to detect tBid was much longer than
that for full-length Bid, suggesting that the amount of tBid
produced was very modest (Figure 4a). Consistent with
this, activated MCM did not cause an appreciable decrease
in the level of full-length Bid. Furthermore, tBid production did
not appear to be related to TNFa (or cell death) as it was not
blocked by the TNFa-neutralizing antibody (Figure 4a) and
was not detected in NPCs treated with rTNFa (data not
shown). Therefore, we examined the expression levels of
other BH3-only family members and interestingly found that
Puma protein levels were consistently increased in response
to both activated MCM and rTNFa treatment (Figure 4a).
Furthermore, we found that neutralization of TNFa blocked
the induction of Puma in response to MCM (Figure 4a). Since
Puma expression is generally regulated at the transcriptional
level, we examined Puma mRNA levels by quantitative
RT-PCR. As shown in Figure 4b, Puma mRNA levels were
not affected in CM from unactivated microglia but were
markedly induced by activated MCM. Furthermore, the
increase in Puma mRNA observed in response to activated
MCM was significantly reduced in the presence of the
Cell Death and Disease
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NF-kB activation by blocking cytokine induced phosphorylation of IkB-a, which binds to NF-kB subunits keeping them
sequestered in an inactive state in the cytoplasm.36 As an
indicator of NF-kB activity, we examined protein levels of
serine-536 phosphorylated (active) p65 subunit. As shown in
Figure 5a, phosphorylated-p65 protein levels were increased
in NPCs following treatment with either MCM or rTNFa and
this was abrogated in the presence of BAY-117082. Importantly, we found that NF-kB inhibition attenuated Puma
induction in response to activated MCM and rTNFa (Figures
5a and b). Consistent with this, BAY-117082 also significantly
reduced MCM and rTNFa induced apoptosis in NPCs
(Figure 5c). Taken together, these results suggest that
NF-kB regulates Puma induction and NPC apoptosis induced
by activated microglia-derived TNFa.

Figure 2 Activated microglia derived TNFa induces NPC apoptosis.
(a) Conditioned stem cell media from unactivated microglia (MCM) or LPSactivated microglia (a-MCM) was collected at the indicated times and incubated in
the presence or absence of TNFa-neutralizing antibody (10 mg/ml) and then
assayed for TNFa levels by ELISA (n ¼ 4). (b) RNA was harvested from NPCs
incubated with increasing concentrations of activated microglia conditioned media
(MCM) for 24 h and TNFR1 and TNFR2 mRNA levels were determined by
qRT-PCR. TNFR1/2 mRNA levels in NPCs incubated in microglia conditioned
media are reported as fold increase over that in NPCs incubated in unconditioned
media (n ¼ 3). (c) NPCs were incubated in unconditioned media (c) or activated
microglia conditioned media (a-MCM) for 24 h and TNFR1 protein levels were
determined by western blot. Representative blot from three independent
experiments is shown. (d) NPCs were cultured in unconditioned stem cell media
(c) or LPS-activated microglia conditioned media (a-MCM) in the presence of TNFaneutralizing antibody or IgG control antibody (10 mg/ml) and the fraction of apoptotic
cells was determined by Hoechst 33342 staining at 72 h (n ¼ 5, *Po0.05).
(e) NPCs were treated with the indicated concentrations of recombinant TNFa
(rTNF) in the presence of TNFa-neutralizing antibody or IgG control antibody
(10 mg/ml) and the fraction of apoptotic cells was determined by Hoechst staining
at 72 h (n ¼ 4, *Po0.05). (f) NPCs were treated with rTNFa (10 ng/ml) in the
presence or absence of the pan-caspase inhibitor zVAD-FMK (100 mM) and the
fraction of dead (ethidium positive) cells was determined by Live/Dead assay at
72 h (n ¼ 4, *Po0.05)

TNFa-neutralizing antibody (Figure 4c). These results indicate that activated microglia-derived TNFa promotes Puma
induction in NPCs.
NF-kB is a well-known mediator of the cellular response
elicited by TNFa signaling and has been shown to regulate the
transcription of both pro-survival and pro-apoptotic genes
depending on the cellular context.27,28 Therefore, we investigated whether activated MCM induces Puma expression in
NPCs via an NF-kB-dependent mechanism. To test this, we
used the pharmacological inhibitor BAY-117082 that inhibits
Cell Death and Disease

Puma is required for NPC apoptosis induced by
neuroinflammation in vitro and in vivo. We next examined whether Puma is necessary for microglia/TNFa induced
NPC apoptosis. To address this, we compared apoptotic
frequencies in NPCs derived from Puma  /  mice and their
wild-type littermates following treatment with CM from
unactivated microglia or increasing concentrations of CM
from LPS-activated microglia. As shown in Figures 6a and b,
apoptosis induced by activated MCM was markedly
reduced in Puma  /  NPCs as compared with wild-type
NPCs. Similarly, we found that rTNFa induced apoptosis was
attenuated in Puma-deficient NPCs (Figure 6c). Taken
together, these results indicate that Puma is required for
the induction of NPC apoptosis by activated microgliaderived TNFa.
SCI induces an inflammatory response associated with the
infiltration of microglia and peripheral immune cells and is
associated with elevated levels of a variety of inflammatory
cytokines including TNFa.37–39 Furthermore, several studies
have reported that inflammatory processes in the injured
spinal cord markedly reduce the survival of transplanted
NPCs.40,41 As we have identified Puma as a key regulator of
microglia induced NPC death in vitro, we next examined
whether Puma plays an important role in regulating NPC
death in the inflammatory environment of the injured spinal
cord in vivo. To address this, we first bred Puma  /  mice with
transgenic mice ubiquitously expressing enhanced green
fluorescent protein (EGFP) under control of the chicken
b-actin promoter (ACTB–EGFP). Puma þ /  /EGFP þ
progeny were then bred to generate Puma þ / þ /EGFP þ and
Puma  /  /EGFP þ embryos from which EGFP-labeled
NPCs were harvested and expanded for transplantation.
K1-15–EGFP transgenic mice that express EGFP exclusively
in keratinocytes were used as recipient mice for NPC
transplants to avoid potential immunogenic responses to
EGFP expression by transplanted NPCs. K15–EGFP mice
received a contusion injury at the T7–8 segment of the spinal
cord, and 1 week after injury, the mice received an intraspinal
injection of equal numbers of NPCs isolated from
either Puma  /  /EGFP mice or Puma þ / þ /EGFP mice. Three
weeks after SCI, mice were euthanized and the number of
surviving EGFP þ NPCs remaining in the lesioned spinal
cords of mice transplanted with Puma þ / þ /EGFP þ or
Puma  /  /EGFP þ NPCs was evaluated. As shown in
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Figure 3 Activated microglia/TNFa-induced NPC apoptosis via a Bax-mediated mitochondrial pathway. NPCs derived from Bax þ / þ and Bax  /  embryos were
maintained in unconditioned stem cell media (c) or treated with LPS-activated microglia conditioned media (a-MCM) or recombinant TNFa (10 ng/ml). (a) Cell death was
assessed at 72 h by Live/Dead assay for 72 h and is reported as the percentage of dead (ethidium positive) cells (n ¼ 4, *Po0.05). Representative images of Live/Dead
staining of Bax þ / þ and Bax  /  NPCs treated with activated microglia conditioned media (a-MCM) for 72 h are shown. Scale bar, 20 mm. (b) Mitochondrial membrane
potential was assessed at 72 h by MitoTracker Red staining and the percentage of MitoTracker negative NPCs is reported (n ¼ 4, *Po0.05). Representative
images of MitoTracker Red and Hoechst 33342 staining in Bax þ / þ and Bax  /  NPCs treated with activated microglia conditioned media (a-MCM) for 72 h are shown.
Scale bar, 20 mm

Figures 7a and b, a substantial number of transplanted
Puma  /  /EGFP þ NPCs remained in the lesioned region of
the cord and the majority of the engrafted cells were located at
the lesion epicenter. In contrast, transplanted Puma þ / þ /
EGFP þ NPCs were rarely detected at the lesion epicenter
and only a few were found at the interface between the lesion
epicenter and the spared neural tissue (Figures 7c and d).
Indeed, the number of engrafted Puma  /  NPCs remaining
in the lesioned spinal cord was B13-fold greater than that of
Puma þ / þ NPCs (3828±1219 versus 297±149; Figure 7e).
These results suggest that similar to the situation in vitro,
Puma plays a prominent role in regulating NPC survival during
neuroinflammation in vivo.
In summary, we have determined that TNFa produced by
activated microglia induces NPC apoptosis via the NF-kBmediated induction of the pro-apoptotic Bcl-2 family member
Puma. Furthermore, we demonstrate that Puma plays a key
role in the regulation of NPC survival during neuroinflammatory responses both in vitro and in the injured nervous
system in vivo.
Discussion
Neuroinflammation is a common feature of acute neurological
injuries as well as many chronic neurodegenerative conditions
and several studies have demonstrated that neuroinflammatory processes can induce apoptosis in NPCs and immature
neurons.11–13,42 Microglia are key regulators of neuroinflammation and depending on the nature of their activation
can produce anti-inflammatory and/or pro-inflammatory

factors and exert either beneficial or detrimental effects on
neurogenesis.2,6 Previous studies have demonstrated
that microglial cells stimulated with LPS to induce a
pro-inflammatory response secrete factors that induce
NPC apoptosis although the underlying mechanisms were
not examined.10,13 Importantly, while previous studies have
suggested a correlation between TNFa and NPC death, our
study is the first to directly implicate TNFa as a key
determinant in microglia induced NPC apoptosis. Specifically,
we demonstrate that neutralization of microglia-derived TNFa
blocks NPC apoptosis induced by activated MCM and that
rTNFa is sufficient to induce NPC death. Consistent with our
findings, it has been reported that acutely activated microglia
that produce high levels of pro-inflammatory cytokines such
as TNFa induce NPC apoptosis whereas chronically activated
microglia that produce low levels of TNFa and increased
levels of anti-inflammatory factors do not induce significant
apoptosis.10 In another study, it was shown that microglia
activated in the presence of the anti-inflammatory factor IL-4
resulted in decreased TNFa production and instead promoted
neurogenesis.43 Interestingly, we also found that expression
of TNFR1, but not TNFR2, is upregulated in NPCs exposed to
activated MCM but that this is not mediated by TNFa as it is
not blocked by TNFa neutralization. This suggests that
TNFR1 induction is triggered by additional microglia-derived
factors that may contribute to NPC death. One interesting
possibility is IL-6 as Monje et al.13 previously reported that
IL-6 contributes to the anti-neurogenic effects of LPSactivated microglia. Interestingly, Iosif and colleagues44,45
have reported that TNFR1 knockout mice exhibit increased
Cell Death and Disease
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Figure 4 Activated microglia derived TNFa induces the expression of the pro-apoptotic Bcl-2 family member Puma. (a) NPCs were incubated in unconditioned stem cell
media (C), unactivated microglia conditioned media (MCM) or LPS-activated microglia conditioned media (a-MCM) in the presence or absence of TNFa-neutralizing antibody
(10 mg/ml). NPCs were harvested after 48 h and protein extracts were subjected to SDS-PAGE and immunoblotted for Bid/tBid, Puma or Actin as a loading control.
Representative blots from three independent experiments are shown. It should be noted that much longer exposure times were required to detect tBid relative to full-length Bid.
(b) RNA was harvested from NPCs treated with increasing concentrations of LPS-activated microglia conditioned media (MCM) for 24 h and Puma mRNA levels were
determined by qRT-PCR. Puma mRNA levels in NPCs treated with MCM is reported as fold increase over NPCs incubated in unconditioned media (n ¼ 4). (c) NPCs were
cultured in unconditioned stem cell media or treated with LPS-activated microglia conditioned media (a-MCM) in the presence of TNFa-neutralizing antibody or IgG control
antibody (10 mg/ml)for 24 h and Puma mRNA levels were determined by qRT-PCR. Puma mRNA levels in NPCs treated with microglia conditioned media ( þ /  antibody) is
reported as fold increase over NPCs incubated in unconditioned media (n ¼ 4, *Po0.05)

neurogenesis in models of epileptic seizure and cerebral
ischemia, although NPC death was not assessed in these
in vivo contexts. While it is likely that TNFR1 induction
potentiates the apoptotic response of NPCs this is yet to be
formally tested.
Depending on the cell type death receptors such as TNFR,
Fas and Trail can trigger apoptosis via a caspase-8dependent mechanism, resulting in direct caspase-3
activation or through an indirect pathway involving Bax/Bakdependent mitochondrial permeabilization.15 We have determined that microglia-derived TNFa as well as rTNFa induce
NPC apoptosis predominately via a Bax-dependent mitochondrial pathway. Specifically, we demonstrate that CM from
activated microglia or rTNFa treatment induces mitochondrial
depolarization and caspase-3 activation in NPCs and that this
is attenuated in Bax-deficient NPCs. BH3-domain-only Bcl-2
family proteins are known to regulate Bax activation in a cell
type and stimulus-specific manner.21,22 It has previously been
reported that in certain cell types, TNFa can trigger apoptosis
through caspase-8-mediated cleavage of the BH3-only family
Cell Death and Disease

member Bid.23,35 However, we have found that NPCs
exposed to activated MCM exhibited only a very modest
increase in tBid levels and that this was not blocked by the
anti-TNF-neutralizing antibody. Furthermore, we did not
detect an increase in tBid in NPCs treated with rTNFa. NPCs
appear to express full-length Bid, thus, the lack of Bid
cleavage suggests that caspase-8 is not efficiently activated
by TNFa in NPCs although the reason for this is not clear.
These results suggest that tBid is not likely required for
activated microglia/TNFa induced apoptosis in NPCs.
On the other hand, we found that NPCs exposed to CM from
activated microglia exhibited a marked increase in the
expression of the BH3-only family member Puma that
appears to be mediated by TNFa as it is suppressed by a
TNFa-neutralizing antibody. Consistent with this, we found
that Puma expression was also induced in NPCs treated with
rTNFa. Importantly, we have demonstrated that Pumadeficient NPCs are remarkably resistant to apoptosis induced
by activated MCM and rTNFa, indicating that Puma induction
is required for cell death.
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Figure 5 Activated microglia-derived TNFa induces Puma expression in NPCs
via an NF-kB-dependent pathway. (a) NPCs were cultured in unconditioned stem
cell media (C) or treated with LPS-activated microglia conditioned media (a-MCM)
or rTNFa (10 ng/ml) in the presence of the NF-kB inhibitor BAY-117082 (10 mM) or
DMSO (0.1%) as a vehicle control. NPCs were harvested at 48 h and protein
extracts were subjected to SDS-PAGE and immunoblotted for phoshphorylated-p65
(Ser536), Puma, and Actin as a loading control. Representative images from three
independent experiments are shown. (b) NPCs were treated with LPS-activated
microglia conditioned media (a-MCM) or rTNFa (10 ng/ml) in the presence or
absence of the NF-kB inhibitor BAY-117082 (10 mM) for 24 h and Puma mRNA
levels were determined by qRT-PCR. Puma mRNA levels are reported as fold
increase over untreated controls (n ¼ 4, *Po0.05). (c) NPCs were treated with
activated microglia conditioned media (a-MCM) or rTNFa (10 ng/ml) in the presence
or absence of BAY-117082 (10 mM) and the fraction of apoptotic cells was
determined at 48 h by Hoechst 33342 staining (n ¼ 4, *Po0.05)

We further examined the importance of this cell death
pathway in an in vivo model of SCI known to involve a marked
inflammatory response including extensive microglia activation and elevated levels of pro-inflammatory cytokines such
as TNFa.39 Previous studies have demonstrated that the
majority of stem cells transplanted into the injured spinal cord
undergo cell death.40,41 Importantly, we have determined that
3 weeks after transplantation, the number of Puma-deficient
NPCs remaining in the injured spinal cord was 413-fold
higher than that of wild-type NPCs. These results are
consistent with the high propensity of NPCs to undergo
apoptotic cell death in a neuroinflammatory environment and
emphasizes the importance of Puma activation in mediating
NPC cell death in vivo.

Figure 6 Puma is required for activated microglia/TNFa-induced NPC
apoptosis. (a) NPCs derived from Puma þ / þ and Puma  /  embryos were
maintained in unconditioned stem cell media (C) or treated with increasing
concentrations of LPS-activated microglia conditioned media (MCM) and the
fraction of apoptotic cells was determined by Hoechst staining at 72 h
(n ¼ 5, *Po0.05, **Po0.01). (b) Representative images of Hoechst staining in
Puma þ / þ and Puma  /  NPCs treated for 72 h with LPS-activated microglia
conditioned media (a-MCM). Scale bar, 20 mm. (c) Puma þ / þ and Puma  / 
NPCs were treated with the indicated concentrations of rTNFa and the fraction of
apoptotic cells was determined by Hoechst staining at 72 h (n ¼ 5, *Po0.05)

Puma expression can be induced by diverse apoptotic
stimuli and is typically regulated through transcriptional
mechanisms.24 Pro-inflammatory cytokines including TNFa
are known to activate NF-kB family transcription factors.26
Indeed, we found that NPCs exposed to activated MCM
exhibited a marked increase in p65 phosphorylation consistent with NF-kB activation. Importantly, we demonstrated that
the NF-kB inhibitor BAY-117082 significantly reduced Puma
induction and NPC apoptosis, indicating that NF-kB is a key
mediator of Puma induction in NPCs exposed to activated
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Figure 7 Transplanted Puma-deficient NPCs exhibit increased survival in the injured mouse spinal cord. K15–EGFP mice received a contusion injury at the T7–8 segment
of the spinal cord. One week after injury, animals received an intraspinal injection of NPCs isolated from either Puma þ / þ /EGFP mice (3  104 cells) or Puma  /  /EGFP mice
(3  104 cells) at the lesion site. Three weeks following injury, mice were killed and spinal cord sections spanning the lesion site were prepared and immunostained with EGFP
antibody and visualized by DAB reaction and hematoxylin counterstain. Representative images of EGFP-stained sections from the lesion site of spinal cord injured mice
transplanted with Puma  /  /EGFP NPCs (a, b) or Puma þ / þ /EGFP NPCs (c, d). Scale bars, 100 and 10 mm (insets). (e) The number of EGFP þ cells remaining in the
injured spinal cord of mice transplanted with Puma þ / þ /EGFP NPCs (n ¼ 6 mice) and Puma  /  /EGFP NPCs (n ¼ 6 mice) was counted in 25 sections/animal and the data
are reported as the mean±S.E.M. (n ¼ 6, *Po0.05)

MCM. Similar to our findings, it has recently been demonstrated that pro-inflammatory cytokines including TNFa can
induce Puma expression via an NF-kB-mediated pathway
in colorectal cancer cells and islet b-cells.46–48 NF-kB has
been reported to promote survival or cell death depending on
the context.27,28 The protective effects of NF-kB have been
attributed to its ability to induce the expression of antiapoptotic factors such as Bcl-2, Bcl-XL, and cIAP2.26
Conversely, NF-kB has been shown to promote apoptosis in
certain conditions by inducing the expression of pro-apoptotic
proteins such as death receptor-5, Fas/Fas ligand, and p53.27
Several studies have suggested that p65 and p53 can
co-operate to activate the expression of pro-apoptotic
genes and promote cell death.49,50 Puma was originally
identified as a p53 responsive gene;24,25 therefore, it is
possible that p53 and NF-kB could act together to promote
Puma induction in NPCs exposed to microglia-derived
pro-inflammatory factors.
In summary, we have identified a key signaling pathway that
regulates neuroinflammation induced apoptosis in NPCs that
could potentially be targeted to promote regeneration and
repair in diverse injury and neurodegenerative conditions.

NPC culture. NPCs were dissociated from the striatum of E13.5 mice and
grown as neurospheres for 7 days in neural stem cell media consisting of DMEMF12 containing D-glucose (6 mg/ml), L-glutamine (2 mM), penicillin/streptomycin,
insulin (20 mg/ml), apotransferrin (100 mg/ml), progesterone (0.02 nM), putrescine
(20 nM), sodium selenite (30 nM), heparin (0.3 nM), and bFGF (10 ng/ml) as
previously described.53 Neurospheres were then dissociated into a single cell
suspension using the NeuroCult chemical dissociation kit (Stem Cell Technologies,
Vancouver, BC, Canada) and plated on dishes coated with poly-L-ornithine and
laminin (Sigma, Oakville, ON, Canada).

Materials and Methods
Animals. Mice carrying a targeting null mutation for Bax were obtained from
Jackson Laboratories (Bar Harbor, ME, USA) and were genotyped as previously
described.51 Mice carrying a targeted null mutation for Puma were generated and
maintained on a C57/BL6 background in the laboratory of Dr. Andreas Strasser
(WEHI, Victoria, Australia) and genotyping of these mice was performed as
previously described.52 K1-15–EGFP and ACTB–EGFP transgenic mice that
express EGFP under the control of the mouse keratin complex-I gene 15 promoter
and the chicken b-actin promoter, respectively, were obtained from Jackson
Laboratories. For the transplantation experiments transgenic ACTB–EGFP mice
were crossed with Puma  /  mice to generate Puma þ /  /EGFP mice. These
progeny were then crossed to generate Puma þ / þ /EGFP and Puma  /  /EGFP
littermates from which NPCs were harvested and expanded for spinal cord
transplantation experiments. Timed pregnant wild-type CD1 mice were purchased
from Charles River Laboratories (Sherbrooke, QC, Canada).

NPC treatments and TNFaneutralization experiments. NPCs were
treated with MCM or recombinant mouse TNFa (rTNFa; R&D Systems,
Minneapolis, MN, USA) 2 days after plating as a monolayer. In the indicated
experiments, the pan-caspase inhibitor carbobenzoxy-valyl-alanyl-aspartyl[O-methyl]- fluoromethylketone (z-VAD-FMK, Santa Cruz Biotech, Santa Cruz,
CA, USA) or the NF-kB inhibitor BAY-117082 (Santa Cruz Biotech) was added to
NPC cultures simultaneously with the switch to MCM or rTNFa treatment. For
TNFa neutralization experiments, MCM was supplemented with 10 mg/ml antimouse TNFa/TNFSF1A (R&D Systems) or 10 mg/ml normal goat IgG as a control
and incubated for 1 h before adding to NPC cultures.

Cell Death and Disease

Microglia cell culture and preparation of MCM. The mouse micrgolial
cell line EOC-20 was obtained from the American Type Culture Collection (ATCC
CRL-2469, Manassas, VA, USA). Cells were maintained at 37 1C and 5% CO2 in
DMEM supplemented with 10% fetal bovine serum, 0.5% penicillin/streptomycin,
4 mM L-glutamine, and 20% conditioned medium from bone-marrow-derived
Ladmac cells (ATCC CRL-2420) as a source of colony stimulating factor-1. To
prepare MCM, EOC-20 cells were grown to 60% confluence at which point their
media was removed and replaced with neural stem cell media (lacking bFGF and
heparin). To activate microglia, NPC media was supplemented with 10 ng/ml LPS
(Sigma) for 24 h. MCM was collected, centrifuged and filtered through a 0.2-mm
filter to remove cells and debris. MCM was then supplemented with 10 ng/ml bFGF
and 0.3 nM heparin and immediately used for NPC cultures. In the indicated
experiments, LPS was added to non-activated MCM or unconditioned stem cell
media immediately before adding to NPC culture. LPS-activated MCM was added
to NPCs either undiluted (100%) or in indicated experiments diluted with CM from
unactivated microglia to yield 25, 50, or 75% activated MCM.

Cell death assays. NPC apoptosis was assessed by examining nuclear
morphology in Hoechst 33342-stained cells as previously described.54 NPCs were
stained with 1 mg/ml Hoechst 33342 (Sigma) and the fraction of cells exhibiting an
apoptotic nuclear morphology characterized by chromatin condensation and/or
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apoptotic bodies, was determined. In certain experiments, NPC death was
determined by Live/Dead assay according to the manufacturer’s instructions
(Invitrogen, Carlsbad, CA, USA) to account for apoptotic and non-apoptotic cell
death. Briefly, NPCs were stained with Calcein-AM (2 mM) and ethidium
homodimer (4 mM) for 20 min and the fraction of live (Calcein-AM positive) and
dead (ethidium positive) cells was scored. NPCs were visualized by fluorescence
microscopy (IX70, Olympus, Richmond Hill, ON, Canada) and images were
captured with a CCD camera (Q-imaging, Burnaby, BC, Canada) and Northern
Eclipse software (Empix Imaging, Mississauga, ON, Canada). Images were
captured and scored by an observer blinded to the treatment. A minimum of 500
cells from five randomly selected fields were analyzed for each treatment and data
represent the mean and S.E.M. from a minimum of four independent experiments.
Determination of mitochondrial depolarization by Mitotracker
Red staining. Mitochondrial membrane potential was assessed using the
potentiometric dye Mitotracker Red as per the manufacturer’s instructions
(Molecular Probes Inc., Eugene, OR, USA). Mitotracker Red is selectively
incorporated into mitochondria with an intact transmembrane potential and loss of
mitochondrial staining can be used as indicator of mitochondrial depolarization.
NPCs were incubated with Mitotracker Red (50 nM) for 30 min at 37 1C and
counterstained with Hoechst 33342. Images were captured as described above
and the fraction of Mitotracker Red positive and negative cells relative to the total
cell number (Hoechst labeled) was scored. Data are presented as the fraction
of cells exhibiting mitochondrial depolarization (Mitotracker Red negative).
A minimum of 500 cells from five randomly selected fields were analyzed for
each treatment and data represent the mean and S.E.M. from a minimum of four
independent experiments.
Caspase-3-like activity assay. NPCs were harvested in lysis buffer
(1 mM KCl, 10 mM HEPES, pH 7.4, 1.5 mM MgCl2, 1 mM PMSF, 5 mg/ml
leupeptin, 2 mg/ml aprotinin, and 10% glycerol) and 10 mg of protein was used in
caspase-3-like activity assay as previously described.55 Briefly, protein samples
were added to caspase reaction buffer (25 mM HEPES (pH 7.4), 10 mM DTT,
10% sucrose, 0.1% CHAPS, and 10 mM N-acetyl-Asp-Glu-Val-Asp-(7-amino-4trifluoromethyl coumarin (Ac-DEVD-AFC)) and fluorescence produced DEVD-AFC
cleavage was measured on a SpectraMax M5 fluorimeter (excitation 400 nm,
emission 505 nm) over a 1-h interval. Caspase-3-like activity is reported as the
ratio of the fluorescence output in NPCs cultured in MCM to NPCs cultured in
unconditioned stem cell media.
TNFa ELISA. Conditioned stem cell media from microglia either left
unstimulated or stimulated with 10 ng/ml LPS (Sigma) was collected at 0, 4, 12,
or 24 h. TNFa levels were detected using the Quantikine ELISA kit (R&D
Systems) as per the manufacturer’s instructions. Briefly, CM samples were added
to microplates pre-coated with mouse polyclonal TNFa antibody. Following
incubation and washes to remove unbound TNFa, an enzyme-linked mouse
polyclonal antibody was added. The addition of the substrate yields a colorimetric
product and the absorbance (450 nm) was measured using a microplate reader.
Samples were assayed in duplicate and TNFa concentrations were determined
from a standard curve using SoftmaxPro software (Molecular Devices, Sunnyvale,
CA, USA).
Quantitative real-time RT-PCR. RNA was isolated using Trizol reagent as
per the manufacturer’s instructions (Invitrogen) and 10 ng of RNA was used in
one-step Sybr green reverse transcription (RT)-PCR (QuantiFast, Qiagen,
Mississauga, ON, Canada). RT-PCR was carried out on a Chromo4 system
(MJ Research Bio-Rad, Mississauga, ON, Canada) and changes in gene
expression were determined by the D(DCt) method using S12 transcript for
normalization as previously described.54 Data are reported as fold increase in
mRNA levels in treated samples relative to corresponding untreated control cells
for each transcript. All PCR’s exhibited high amplification efficiency (490%) and
the specificity of PCR products was confirmed by sequencing. Primer sequences
used for gene-specific amplification are available on request.
Western blot analysis. To prepare whole-cell lysates, NPCs were incubated
in lysis buffer (150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS,
50 mM Tris pH 8, 1 mM EDTA, 1 mM DTT, and protease and phosphatase inhibitor
cocktail (Invitrogen) for 20 min on ice and soluble extract was recovered
by centrifugation. Protein concentration was determined by BCA assay

(Pierce, Rockford, IL, USA) and 40 mg of protein was separated on 12.5%
SDS-PAGE gels and then transferred to nitrocellulose membranes. Membranes
were blocked for 1 h in TBS-T (10 mM Tris, 150 mM NaCl, 0.05% Tween-20),
followed by overnight incubation in primary antibodies to Bid/tBid (R&D Systems),
Puma, phospho(ser536)-p65 (Cell Signaling Technology, Danvers, MA, USA),
Tnfr1 or Actin (Santa Cruz Biotech) in TBS-T containing 5% skim milk. Membranes
were washed with TBS-T and incubated for 1 h with the appropriate HRPconjugated secondary antibodies and developed by enhanced chemiluminescence
system according to the manufacturer’s instructions (ThermoScientific, Ottawa,
ON, Canada).
Mouse model of SCI and NPC transplantation. All protocols for these
experiments were approved by the University of Western Ontario Animal Care
Committee in accordance with the policies established in the Guide to Care and
Use of Experimental Animals prepared by the Canadian Council on Animal Care.
A total of 12 adult female C57B6-Kr15–EGFP mice weighing 18–22 g were
anesthetized with Ketamine (100 mg/kg) and xylazine (10 mg/kg) and subjected to
SCI as previously described.56 Kr15–EGFP mice that express EGFP exclusively in
hair follicle bulge cells were used in these experiments to avoid a potential
immunogenic response induced by transplantation of EGFP expressing NPCs.
Briefly, the vertebral column was stabilized at T6 and T10 and a laminectomy was
performed by exposing the dura matter at spinal cord level T7–8. Spinal cord
contusion was performed using the Infinite Horizon Impactor (Precision Systems
and Instrumentation, Fairfax, VA, USA) with 50 kdyn and 1 s dwelling time. After
surgery, mice were kept at 37 1C and closely monitored. Urine was expressed
manually twice per day, and mice were checked daily to monitor their overall
health. NPC transplantation was performed 7 days after SCI. The dura was incised
with the tip of an injection needle exposing the surface of the injured spinal cord.
Puma þ / þ /EGFP NPCs (3  104 cells/3 ml, six mice) or Puma  /  /EGFP NPCs
(3  104 cells/3 ml, six mice) were injected into the cord at the lesion site using a
spinal stereotaxic frame by means of a glass pipette (tip diameter 100 mm)
configured to a 10-ml Hamilton syringe. Each SCI mouse was transplanted with
NPCs derived from an independent Puma  /  /EGFP or Puma þ / þ /EGFP donor
mouse (n ¼ 6 for each genotype).
Immunohistochemistry. At 21 days after injury, mice were transcardially
perfused with 4% paraformaldehyde in phosphate-buffered saline (PBS). The
T2–L1 vertebral segments, which included the site of the contusion injury, were
removed and processed for cryo-sectioning and immunohistochemistry as
previously described.56 Transverse sections (16 mm) of spinal cord were serially
collected and mounted on glass slides. Every 10th section (25 sections out of
250 sections from each cord), spanning B4 mm in length across the lesion site
(B2 mm caudal to B2 mm rostral to the lesion epicenter), was stained for EGFP
expression. The slides were incubated with rabbit anti-EGFP antibody (1 : 300;
Invitrogen) in a humidified chamber at 4 1C overnight and the signal was visualized
by a peroxidase-DAB reaction (Zymed, Carlsbad, CA, USA) and hematoxylin
counterstain. The immunostained sections were examined using an Olympus
epifluorescence microscope (BX51) and the total number of EGFP þ NPCs in the
25 sections/animal was counted.
Data analysis. Data are reported as mean and standard error of the mean.
The n value represents the number of independent experiments and/or number of
mice from which independent NPC cultures were prepared. Data were analyzed
by one-way ANOVA followed by Tukey’s post-hoc test and differences were
considered significant at Po0.05. All statistical analyses were conducted using
GraphPad Prism software (GraphPad Software Inc., La Jolla, CA, USA).
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